triptolide has been researched along with Proteinuria in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Ji, B; Liu, J; Ma, Y; Shen, Q; Xu, H; Yin, Y; Yu, J | 1 |
Ji, B; Liu, J; Shen, Q; Xu, H; Yin, Y; Yu, J | 1 |
Chen, D; Fu, L; Gu, J; He, L; Jing, Y; Li, L; Mei, C; Mei, S; Qi, N; Wu, M; Yang, M; Zhang, D | 1 |
Chen, Z; Hou, Q; Liu, Z; Wang, L; Zhang, L; Zhu, X | 1 |
Chen, H; Li, Z; Song, H; Sun, L; Tang, X; Wang, D; Yan, Q; Zhao, X | 1 |
Du, L; Fu, H; Jin, X; Liu, A; Mao, J; Shen, H; Shu, Q; Wang, J; Wu, L | 1 |
Chen, D; Dai, B; Li, L; Liu, H; Liu, S; Ma, Y; Mao, Z; Mei, C; Wang, X; Yu, S | 1 |
Chen, ZH; Li, LS; Liu, ZH; Qin, WS; Zeng, CH; Zheng, CX | 1 |
Chen, ZH; Hong, YM; Li, LS; Liu, ZH; Lu, YZ; Qin, WS; Zeng, CH; Zheng, CX | 1 |
Cao, L; Chen, Y; Du, L; Fu, H; Liu, A; Mao, J; Wang, D; Xia, Y; Yao, S | 1 |
Dong, J; Liu, MX; Xu, HB; Yang, XL; Yang, YJ | 1 |
1 trial(s) available for triptolide and Proteinuria
Article | Year |
---|---|
Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China.
Topics: Biopsy; Child; Child, Preschool; China; Diterpenes; Drugs, Chinese Herbal; Epoxy Compounds; Female; Humans; IgA Vasculitis; Kaplan-Meier Estimate; Male; Nephritis; Phenanthrenes; Proteinuria | 2013 |
10 other study(ies) available for triptolide and Proteinuria
Article | Year |
---|---|
Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
Topics: Angiopoietin-Like Protein 3; Animals; Doxorubicin; Female; Kidney Diseases; Mice; Mice, Knockout; Podocytes; Proteinuria; Transforming Growth Factor beta1; Tumor Suppressor Protein p53 | 2023 |
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Autophagy; Doxorubicin; Female; Kidney Diseases; Mice; Mice, Inbred C57BL; Proteinuria | 2023 |
Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Cell Line; Cell Proliferation; Creatinine; Disease Models, Animal; Disease Progression; Diterpenes; Epoxy Compounds; Humans; Interleukin-6; Janus Kinase 2; Kidney; Male; Phenanthrenes; Phosphorylation; Polycystic Kidney Diseases; Proteinuria; Rats, Transgenic; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein | 2018 |
Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B.
Topics: Animals; Animals, Genetically Modified; Anti-Infective Agents; Antigens, Differentiation; Apoptosis; Cells, Cultured; Diterpenes; Epoxy Compounds; Humans; Immunosuppressive Agents; Metronidazole; NF-kappa B; Phenanthrenes; Podocytes; Proteinuria; Zebrafish; Zebrafish Proteins | 2018 |
Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation.
Topics: Animals; Antibodies, Antinuclear; Antirheumatic Agents; Cell Proliferation; Disease Models, Animal; Diterpenes; Epoxy Compounds; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; MicroRNAs; Phenanthrenes; Proteinuria; T-Lymphocytes, Regulatory; Up-Regulation | 2019 |
Triptolide-containing formulation in patients with autosomal dominant polycystic kidney disease and proteinuria: an uncontrolled trial.
Topics: Adult; Diterpenes; Epoxy Compounds; Female; Humans; Male; Medicine, East Asian Traditional; Middle Aged; Phenanthrenes; Phytotherapy; Polycystic Kidney, Autosomal Dominant; Proteinuria; Treatment Outcome; Tripterygium | 2014 |
Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
Topics: Animals; Cells, Cultured; Cholesterol; Cytoskeleton; Desmin; Diterpenes; Epoxy Compounds; Glomerular Filtration Rate; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Membrane Proteins; Mice; Nephrosis; Phenanthrenes; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Reactive Oxygen Species; Serum Albumin; Triglycerides | 2008 |
Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
Topics: Administration, Oral; Animals; Cell Line; Complement Membrane Attack Complex; Cytoprotection; Desmin; Disease Models, Animal; Diterpenes; Epoxy Compounds; Female; Glomerulonephritis, Membranous; Heymann Nephritis Antigenic Complex; Immunoglobulin G; Immunosuppressive Agents; Mice; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phenanthrenes; Podocytes; Proteinuria; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Tacrolimus; Time Factors | 2010 |
Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.
Topics: Adolescent; Biopsy; Chi-Square Distribution; Child; Child, Preschool; China; Diterpenes; Drug Therapy, Combination; Epoxy Compounds; Female; Hematuria; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Nephritis; Nephrotic Syndrome; Phenanthrenes; Prednisone; Proteinuria; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
[Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Delayed-Action Preparations; Diterpenes; Drug Carriers; Drug Delivery Systems; Epoxy Compounds; Lactic Acid; Male; Nanotechnology; Particle Size; Phenanthrenes; Polyesters; Polymers; Proteinuria; Rats; Rats, Wistar; Tripterygium | 2004 |